NON-SMALL CELL LUNG CANCER (NSCLC)

This study tested whether the drug osimertinib could help control a serious complication where lung cancer spreads to the membranes surrounding the brain and spinal cord. It involved 73 adults in South Korea with a specific genetic mutation in their lung cancer who had already tr…

This study tested a new method to make radiation therapy for lung cancer more accurate. Small beacon devices were implanted near the tumor to track its exact location while patients held their breath during treatment. Researchers wanted to see if this approach was practical and s…

This study tested whether a new two-drug immunotherapy combination (atezolizumab + tiragolumab) works better than the standard single immunotherapy (durvalumab) for people with stage III non-small cell lung cancer that cannot be surgically removed. The trial involved 829 patients…

This study looked back at medical records to see how well a combination of immunotherapy (nivolumab) and chemotherapy worked for Argentinian patients with early-stage, operable lung cancer. The goal was to see if this treatment given before surgery could completely eliminate the …

This Phase 2 trial tested a personalized treatment approach for patients with locally advanced non-small cell lung cancer (NSCLC). For patients whose tumors had high levels of a specific marker (PD-L1), researchers combined a 4-week personalized radiation course with an immunothe…

This study tested whether adding the experimental drug tiragolumab to the existing drug atezolizumab could better prevent lung cancer from returning in people who had already undergone surgery and chemotherapy. It involved 56 people with early-stage non-small cell lung cancer tha…

This study tested whether adding a new drug called tiragolumab to a standard immunotherapy and chemotherapy regimen works better than the current standard treatment for people with advanced non-small cell lung cancer who haven't had prior treatment. It involved 542 participants w…

This early-phase study tested whether combining a short, intense course of radiation with two immunotherapy drugs is safe for patients with advanced cancers that have spread. The trial involved 53 adults with metastatic melanoma, lung, breast, or pancreatic cancer who had tried o…

This study aimed to see if adjusting how a standard PET/CT scan is performed could make it more accurate for determining if non-small cell lung cancer has spread to nearby lymph nodes. It involved 30 adult patients who were already scheduled for a standard staging scan. The resea…